Posted by ABMN Staff on May 8th, 2024
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) CEO Sarah Boyce sold 28,000 shares of the stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $25.54, for a total transaction of $715,120.00....
More of this article »